Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial. Issue 1 (December 2016)

Record Type:: Journal Article
Title:: Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial. Issue 1 (December 2016)
Main Title:: Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial
Authors:: Yardley, Denise
Brufsky, Adam
Coleman, Robert
Conte, Pierfranco
Cortes, Javier
Glück, Stefan
Nabholtz, Jean-Mark
O'Shaughnessy, Joyce
Beck, Robert
Ko, Amy
Renschler, Markus
Barton, Debora
Harbeck, Nadia
Abstract:
Is Part Of:: Trials. Volume 17:Issue 1(2016)
Journal:: Trials
Issue:: Volume 17:Issue 1(2016)
Issue Display:: Volume 17, Issue 1 (2016)
Year:: 2016
Volume:: 17
Issue:: 1
Issue Sort Value:: 2016-0017-0001-0000
Page Start:: 1
Page End:: 1
Publication Date:: 2016-12
Subjects:: Group-randomized trials -- Periodicals
Randomized Controlled Trials -- Periodicals
615.0727
Journal URLs:: http://www.pubmedcentral.gov/tocrender.fcgi?iid=11709 ↗
http://www.trialsjournal.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1186/s13063-016-1195-6 ↗
Languages:: English
ISSNs:: 1745-6215
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 9819.xml